                         SEQUENCE LISTING

<110>  The Government of the United States of America as 
       represented by the Secretary of the Department of Health and 
       Human Services, Centers for Disease Control and Prevention
 
<120>  COMPOSITIONS AND METHODS FOR SIMULTANEOUS DETECTION OF HCV 
       ANTIGEN/ANTIBODY

<130>  CDC-19152/38

<150>  US 61/821,953
<151>  2013-05-10

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HCV core protein sequence Accession No: AB719482.1

<400>  1

Met Ser Thr Asn Pro Lys Pro Gln Arg Lys Thr Lys Arg Asn Thr Asn 
1               5                   10                  15      


Arg Arg Pro Gln Asp Val Lys Phe Pro Gly Gly Gly Gln Ile Val Gly 
            20                  25                  30          


Gly Val Tyr Leu Leu Pro Arg Arg Gly Pro Arg Leu Gly Val Arg Ala 
        35                  40                  45              


Thr Arg Lys Thr Ser Glu Arg Ser Gln Pro Arg Gly Arg Arg Gln Pro 
    50                  55                  60                  


Ile Pro Lys Ala Arg Gln Pro Glu Gly Arg Ala Trp Ala Gln Pro Gly 
65                  70                  75                  80  


Tyr Pro Trp Pro Leu Tyr Gly Asn Glu Gly Leu Gly Trp Ala Gly Trp 
                85                  90                  95      


Leu Leu Ser Pro Arg Gly Ser Arg Pro Ser Trp Gly Pro Thr Asp Pro 
            100                 105                 110         


Arg Arg Arg Ser Arg Asn Leu Gly 
        115                 120 


<210>  2
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  protein synthetic sequence

<400>  2

Asn Thr Asn Arg Arg Pro Gln Asp Val Lys Phe Pro Gly Gly Gly Gln 
1               5                   10                  15      


Ile Val 
        


<210>  3
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  protein synthetic sequence

<400>  3

Arg Lys Thr Ser Glu Arg Ser Gln Pro Arg Gly Arg Arg Gln Pro Ile 
1               5                   10                  15      


Pro Lys Ala Arg Gln Pro Glu Gly Arg Ala Trp Ala Gln Pro Gly Tyr 
            20                  25                  30          


Pro Trp Pro Leu Tyr Gly Asn Glu Gly Leu 
        35                  40          


<210>  4
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  protein synthetic sequence

<400>  4

Ser Gly Gly Gly Gly Ser Gly Gly Gly Ser 
1               5                   10  


